Section Arrow
Quote
INMD.NASDAQ
- InMode Ltd
Quotes are at least 15-min delayed:2026/03/09 18:58 EDT
After Hours
Last
 13.29
0 (0.00%)
Bid
13.01
Ask
13.29
High 13.29 
Low 13.03 
Volume 5.73K 
Regular Hours (Closed)
Last
 13.29
+0.06 (+0.45%)
Day High 
13.295 
Prev. Close
13.23 
1-M High
15.3907 
Volume 
1.46M 
Bid
13.01
Ask
13.29
Day Low
12.949 
Open
13.1 
1-M Low
13.2 
Market Cap 
838.24M 
Currency 美元 
P/E 9.25 
%Yield -- 
10-SMA 13.74 
20-SMA 14.22 
50-SMA 14.57 
52-W High 19.78 
52-W Low 13.14 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.43/1.68
Enterprise Value
843.24M
Balance Sheet
Book Value Per Share
10.78
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
370.50M
Operating Revenue Per Share
7.87
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
After Hours 112.2 -0.45 -0.40%
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
After Hours 71.76 -0.14 -0.19%
MDTMedtronic plc91.34+0.44+0.48%25.39PE
After Hours 91.25 -0.09 -0.10%
BFLYButterfly Network3.76+0.11+3.01%-- 
After Hours 3.74 -0.02 -0.53%
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
After Hours 1.3999 +0.0099 +0.71%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF,and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.